Skip to Content

The Cigna Group

CI: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$722.00SlkpthMcxxlngkf

Cigna: Squashes Humana Deal Rumors by Announcing Other Capital Allocation Priorities

After merger rumors surrounded narrow-moat Cigna and Humana in recent weeks, Cigna announced other capital allocation priorities that look more appropriate to us, especially given antitrust concerns that likely would have surrounded the pharmacy benefit management part of the rumored combination. We are keeping our fair value estimates for both organizations intact. Following their decline since deal rumors were highlighted a couple of weeks ago, Cigna's shares look especially attractive relative to our fair value estimate.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CI so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center